Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
2.955
-0.055 (-1.83%)
Apr 29, 2026, 9:59 AM EDT - Market open
Anixa Biosciences Balance Sheet
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 1.55 | 1.24 | 1.27 | 0.92 | 12.36 | 29.13 | Upgrade
|
| Short-Term Investments | 12.66 | 13.93 | 18.65 | 22.93 | 17.33 | 6.6 | Upgrade
|
| Cash & Short-Term Investments | 14.2 | 15.17 | 19.92 | 23.84 | 29.69 | 35.73 | Upgrade
|
| Cash Growth | -17.69% | -23.84% | -16.44% | -19.68% | -16.91% | 294.47% | Upgrade
|
| Other Receivables | - | - | 0.17 | 0.27 | 0.05 | - | Upgrade
|
| Receivables | - | - | 0.17 | 0.27 | 0.05 | - | Upgrade
|
| Prepaid Expenses | 0.85 | 0.71 | 1.27 | 1.24 | 0.47 | 0.28 | Upgrade
|
| Total Current Assets | 15.05 | 15.89 | 21.36 | 25.36 | 30.2 | 36 | Upgrade
|
| Property, Plant & Equipment | 0.18 | 0.19 | 0.23 | 0.17 | 0.21 | 0.25 | Upgrade
|
| Total Assets | 15.23 | 16.08 | 21.59 | 25.52 | 30.41 | 36.26 | Upgrade
|
| Accounts Payable | 0.15 | 0.17 | 0.53 | 0.21 | 0.27 | 0.14 | Upgrade
|
| Accrued Expenses | 1.05 | 1.76 | 1.95 | 1.77 | 1.73 | 1.1 | Upgrade
|
| Current Portion of Leases | 0.04 | 0.04 | 0.03 | 0.05 | 0.05 | 0.04 | Upgrade
|
| Total Current Liabilities | 1.24 | 1.97 | 2.5 | 2.03 | 2.04 | 1.27 | Upgrade
|
| Long-Term Leases | 0.15 | 0.16 | 0.2 | 0.12 | 0.18 | 0.22 | Upgrade
|
| Total Liabilities | 1.39 | 2.13 | 2.7 | 2.15 | 2.21 | 1.49 | Upgrade
|
| Common Stock | 0.34 | 0.33 | 0.32 | 0.31 | 0.31 | 0.3 | Upgrade
|
| Additional Paid-In Capital | 268.98 | 266.51 | 260.43 | 252.22 | 247.12 | 239.93 | Upgrade
|
| Retained Earnings | -254.24 | -251.68 | -240.75 | -228.2 | -218.39 | -204.79 | Upgrade
|
| Treasury Stock | - | - | -0.01 | - | - | - | Upgrade
|
| Total Common Equity | 15.08 | 15.16 | 20 | 24.34 | 29.05 | 35.44 | Upgrade
|
| Minority Interest | -1.23 | -1.21 | -1.11 | -0.97 | -0.85 | -0.67 | Upgrade
|
| Shareholders' Equity | 13.85 | 13.95 | 18.89 | 23.37 | 28.2 | 34.77 | Upgrade
|
| Total Liabilities & Equity | 15.23 | 16.08 | 21.59 | 25.52 | 30.41 | 36.26 | Upgrade
|
| Total Debt | 0.19 | 0.2 | 0.23 | 0.18 | 0.22 | 0.26 | Upgrade
|
| Net Cash (Debt) | 14.01 | 14.97 | 19.69 | 23.67 | 29.47 | 35.47 | Upgrade
|
| Net Cash Growth | -17.71% | -23.98% | -16.80% | -19.67% | -16.92% | 294.01% | Upgrade
|
| Net Cash Per Share | 0.43 | 0.46 | 0.62 | 0.76 | 0.97 | 1.24 | Upgrade
|
| Filing Date Shares Outstanding | 33.53 | 33.38 | 32.19 | 31.7 | 30.92 | 30.13 | Upgrade
|
| Total Common Shares Outstanding | 33.46 | 33.01 | 32.19 | 31.15 | 30.91 | 30.05 | Upgrade
|
| Working Capital | 13.81 | 13.92 | 18.86 | 23.33 | 28.16 | 34.73 | Upgrade
|
| Book Value Per Share | 0.45 | 0.46 | 0.62 | 0.78 | 0.94 | 1.18 | Upgrade
|
| Tangible Book Value | 15.08 | 15.16 | 20 | 24.34 | 29.05 | 35.44 | Upgrade
|
| Tangible Book Value Per Share | 0.45 | 0.46 | 0.62 | 0.78 | 0.94 | 1.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.